Presenter: Dr Anil Meetei
Moderator: Dr Th Chito
Asst prof, CTVS
Endovascular surgery
Endovascular surgery is a form of minimally invasive
surgery/procedures for imaging the circulation or for
treating vascular disorders from within the circulation,
through catheters/miniature instruments inserted
percutaneously into the blood vessels
Scope of endovascular therapy
 Baloon angioplasty
 Endovascular cryotherapy
 Stenting
 Angioscopy /intravascular ultrasound
 Atherectomy
 Thromb0embolectomy /intraarterial thrombolysis
 Embolization
 Endovascular aneurysm repair (EVAR)
 Endovenous laser ablation (EVLA)
 Endovascular RFA
 Transcatheter aortic valve implantation (TAVI)
 Percutaneous mitral valve repair
 Basic instruments
 Needles
 Guidewires
 Catheters
 Sheaths
Endovascular device sizing
 DEVICE MEASUREMENT UNIT
1. Entry needle outer diameter gauge
2. Guide wire outer diameter inch
3. Sheath inner diameter french
4. Guiding outer diameter french
catheter
5. diagnostic outer diameter french
catheter
 Common interventions
 Balloons
 Stents
 Stent grafts
 Filters
 Thrombolytics
 Closure devices
 IVUS
 Contrast media
 Ionic
 Non ionic
Contrast agents
Iso osmolar-iodixanol, iotrolan(non ionic)
Low osmolar
Ionic dimer-meglumine ioxaglate
Non ionic monomer- iopamidol, iohexol(omnipaque),
ioversol, iopromide
High osmolar
Ionic monomer- meglumine diatrzoate(hypaque,
gastrograffin, urograffin)
 ACCESS
 Common femoral artery, popliteal, tibial, axillary,
brachial, radial, carotid, subclavian
 Bone/bony prominence beneath the artery
 Avoid diseased areas
 Away from side brances, bifurcations, or crossing veins
 External skin markings, ultrasound guided, fluoroscopy
 Puncture site: common femoral artery on the medial
3rd of femoral head 1-2 cm below the inguinal ligament
 A puncture site below the ligament cannot be
compressed and could result in a large pelvic
hemorrhage
 Puncture of the SFA must be avoided to prevent
pseudo-aneurysm and hematoma correlate to the
inefficacy of the compression
 ACCESS
 1. Retrograde-relatively large diameter, ease of
compression, options for image guided puncture
 2. Antegrade- commonly used for infrageniculate
interventions, aortic bifurcations that are prohibitive
to a contralateral retrograde CFA access and for
chronic total occlusions
 straight line approach- easy maneuvering
 ACCESS
 1. Single wall Puncture
 2. Double wall Puncture
Guidewires
 • Composite construction
 • Materials
 – Stainless Steel
 – Nitinol
 – Jacketed Composite
 Hydrophilic/hydrophobic
 • Core
 • Stainless Steel
– Used for support
– Stiffness varies based on taper / diameter of core
 • Nitinol
– Used for it’s flexibility, memory and kink resistance
 • Tip
 • Platinum / Gold
– Provides radiopacity
– Atraumatic
– Ribbon formed for shaping tip
Grind & tip performance
 • Stiff
 • Intermediate
 • Floppy
Sheaths
 Sheaths are hemostatic conduits inserted into the
vessel. They allow passage of guidewires, catheters and
interventional devices.
 Hemostatic valve at the tip and a side port for
aspiration/administration of drugs
 Helps minimize local trauma to the vessel from
repeated exchanges as well as decrease blood loss and
hematoma formation
Sheaths
 Peripheral and coronary sheaths have a universal color code
 Universal color coding
4 Fr = red
5 Fr = gray
6 Fr = green
7 Fr = orange
8 Fr = blue
9 Fr = black
10 Fr = violet
11 Fr = yellow
 Sheaths are measured inner diameter in french size (1fr =
.33mm)
catheters
• Guide catheter
• Diagnostic catheter
• Non selective
• Selective
• Crossing
Endovascular surgery
 Typically performed under LA
 Less invasive
 Quicker return to function
 Durability compared to open surgical options
 Highly skilled operator
 Endovascular suite with fluoroscopy
 Costly
Complications of endovascular
procedures
 Systemic, access site, or wire/catheter related complications
 Contrast induced nephropathy
 Increase age(>75 yrs), CRF(creatinine>1.5mg/dl), heart failure, DM,
preprocedural hypotension, anaemia , ionic contrast medium
 Proper hydration, Minimum contrast dose
 Access site-MC
 Hematoma(3%), thrombosis(2%), bleeding, AVF, pseudoaneurysm
 Hematoma-reversal of anticoagulation, vol resuscitation,
hematoma evacuation
 Catheter related-
 dissection, distal embolization, perforation
Seldinger technique
 Sven Ivar Seldinger- Swedish radiologist (1953)
 The Seldinger technique is a medical procedure to obtain safe access
to blood vessels
 The desired vessel is punctured with a sharp hollow needle called a
trocar, with ultrasound guidance .
 Guidewire is then advanced through the lumen of the trocar, and the
trocar is withdrawn. A "sheath" or blunt cannula is passed over the
guidewire into the cavity or vessel. After passing a sheath or tube, the
guidewire is withdrawn.
 A sheath can be used to introduce catheters or other devices to perform
endoluminal procedures.
 Fluoroscopy is used to confirm the position of the catheter and to
manoeuvre it to the desired location. Injection of radiocontrast may be
used to visualize organs.
 Upon completion of the desired procedure, the sheath is withdrawn. a
sealing device may be used to close the hole made by the procedure.
Balloon angioplasty
 Fogarthy (1963)- used endovascular catheter for extraction of arterial
emboli and thrombi
 Dotter and Judkins (1964)-transluminal treatment of arterial stenosis
 Types
 Percutaneous transluminal angioplasty (PTA)
 Subintimal angioplasty
 PTA with stenting
Technique
 Shortest distance from the access vessel to the target vessel
 Retrograde right common femoral artery access
 Tibial occlusive disease-I/L anterior common femoral access
 Heparinization-5000 IU as standard bolus dose after arterial
access. 1000 IU/L heparinized saline for flushing
 Arteriography to identify the lesion and severity
 Lesion crossed and contrast injected
 Balloon diameter and length carefully chosen
 IVUS/CTA- for sizing the lesion
 Balloon inflated for 1 min, withrawn after deflating
 Contrast injection to assess the PTA result
 Iliac and femoro popliteal segments. Less successful
for below knee narrowing
 Coronary arteries
 Complications- failure, hematoma formation,
bleeding, thrombosis, distal embolisation
Subintimal angioplasty
 Bolia et al (1989)-for chronic total occlusions
 Creating an intentional subintimal plane across the occlusion
with a guidewire and wire redirected back into the true lumen
 Iliac and femoropopliteal occlusions- successful in highly
calcified lesions, long occlusions(>15 cm)
 Higher patency rates were observed in limbs treated for
claudication than limbs treated for chronic total occlusions
and criticallimb ischaemia
 12 month patency <70%
 Mean increase in ABI is 0.3
 Technical failure rate ~26%- mostly due to inability to reenter
the true lumen distal to the occlusion(70%)
 Types of balloon
 Complaint balloon
 Non complaint balloon
Complaint balloon
–expand in the direction of least resistance
- more potential for arterial injury
-potentially treat vessels of varying diameter
Non complaint balloon
-polyolefin copolymer/polyethylene/nylon reinforcement
-provide higher uniform dilating force –highly calcific
lesions
 Cutting balloon angioplasty-
 Ballon loaded with metal atherotome or microsurgical blades
 Designed to create controlled incisions into the thrombus
and dilate the vessel with less force than conventional balloon
angioplasty
 CBA- reasonable option for infrainguinal vein graft stenosis
-superior results to PTA
-more chance of perforation
 Endovascular cryotherapy
 Balloon catheter inflated with nitrous oxide delivering cold
thermal energy(-10 C) to the arterial wall.
 Alters healing response after angioplasty, principally inducing
smooth muscle cell apoptosis rather than necrosis, thus
reducing myointimal hyperplasia
 CLIMB study
-initial success rate 95%
-stents required in 17%
-primary patency at 12 months @56% and comparible with
those achieved with conventional PTA
-recommended for lesions >55mm
 Drug coated balloons(DCBs)
 Substantial amounts of antiproliferative agents were delivered
to the arterial wall during short periods of balloon inflation.
 For prevention of re stenosis and myointimal hyperplasia
 Paclitaxel coated balloons deliver drug during balloon
inflation( superficial femoral artery)
 Drug eluting stents (DES)
-coronary circulation/infrainguinal arterial occlusive disease
-Sirolimus/paclitaxel-inhibits smooth muscle cell proliferation
Stenting
 Stent-comes from 19th century London dentist-
Charles Stent
 Charles Dotter (1983)-nitinol stents were first used
 Palmaz et al (1985)-balloon expandable stent
 Two types
 Bare metal stent
 Stent graft
 Two types based on deployment method
 Balloon expandable
 Self expanding
Balloon expandable Self expandable
 High radial/longitudinal
force
 Precise placement
 Further expansion with larger
balloons
 Radiopaque
 Short length
 Prone to crushing
 Flexibility
 Long stent lengths
 Continued radial force if
oversized
 Crush resistant
 Ability to clamp the stent
 Low radial force
 Inaccurate/less precise
placement
 Limited radiopacity
Angioscopy
 Used for visualizing the interior of blood vessels
 Arterial embolism, adjunctive procedure during
vascular bypass to visualize valves within venous
conduit
 Visualize stents in catheterization lab
Intravascular ultrasound
 Uses miniature ultrasound probe attached to distal
end of an intravascular catheter(uses 20-40MHz)
 Useful with unreliable angiographic images-lumen of
ostial lesions, or in regions with multiple overlapping
arterial segments
 Advantages over angiography-measures atheroma
hidden within the vessel wall, identifies vulnerable
plaque. Measures the effect of different treatment
strategies for changing the evolution of the
atherosclerosis disease process
Atherectomy
 Endovascular atherectomy allows the physical removal of
atherosclerotic plaque material from the blood vessel, with a
theoretical benefit of removing the obstructing plaque rather
than mere displacing it, as with angioplasty and stenting
 Open atherectomy remains the gold standard. Endovascular
atherectomy is useful in vessels with difficult access
 Excisional atherectomy catheters remove and collect the
atheroma, whereas ablative device fragment the atheroma into
small particles
 3 types of atherectomy devices
 Directional
 Rotational
 Laser
 Directional atherectomy
 Best suited for discrete calcified atherosclerotic lesions
of infrainguinal arteries. Not used for chronic total
occlusion
 Silverhawk plaque excision system-the device is
advanced under fluoroscopic guidance to the proximal
portion of the target lesion, where a carbide cutter excise
the atheroma and traps it within the nose come of the
device; once filled with plaque the device is removed,
the nose cone is emptied, and the device is reintroduced
over a guidewire
 Rotational atherectomy utilizes a rotating burr or
blade to excise plaque, whose microparticles are either
aspirated or allowed to embolize distally
 Jetstream – device success rate 99%.TLR -15% and 26%
at 6 and 12 months respectively; restonosis 38% at 1yr
 May cause vasospasm-calcium channel blockers/
nitroglycerine
 Laser atherectomy
 Utilized in CTOs, both de novo or in in stent thrombosis
 Cold tip laser that delivers burst of ultraviolet xenon
energy in short pulse duration.
 Key features is the ability to debulk tissue without
damaging surrounding tissue, minimizing restenosis
COMPLICATIONS
-embolism 1.3%
Thromboembolectomy
 Management of acute thrombotic or embolic arterial
occlusions
 Fogarty catheter
 Purely percutaneous thrombolectomy
 Aspiration
 Rheolytic devices
 Mechanical fragmentation with or without
pharmacologic lysis
 Simple aspiration either via a large sheath or guide
catheter work well in small vessels< 6mm
 Rheolytic devices utilize jets of saline, directed from
the tip of the catheter back toward its more proximal
portion, to create a venturi effect, resulting in clot lysis
and aspiration.
 Arterial access is ideally made antegrade to the area of
thrombotic occlusion. Lower extremity lesions are
approached through contralateral femoral artery
Inferior vena cava filter
 Prevent life threatening pulmonary emboli
 Retrievable/ permanent
 Indications
 DVT/PE with contraindications to anticoagulation
 Recurrent VTE despite adequate anticoagulation
 Poor patient compliance(INR unstable), thrombolysis
Complications-device migration, filter embolization, filter
fracture, perforation of IVC, recurrent DVT, vena cava
thrombosis
Intraarterial thrombolysis
 In IA thrombolysis, the cervicocephalic arterial tree is
traversed with an endovascular microcatheter delivery
system, the catheter port is positioned immediately within
and adjacent to the offending thrombus, and fibrinolytic
agents are infused directly into the clot. This delivery
technique permits high concentrations of lytic agent to be
applied to the clot while minimizing systemic exposure.
 In acute ischaemic stroke within 6 hours of symptom onset
 It is usually infused over 1 to 2 hours while serial
angiographic studies are obtained
 reduced hemorrhagic complications (due to the use of
lower doses of pharmacologic thrombolytics
 Myocardial infarction, ischaemic stroke, massive PE,
acute limb ischaemia
 Recanalization rates for IAT have been shown to be
superior to those for IVT for major cerebrovascular
occlusions, averaging 70% versus 34%
 Agents used
 Streptokinase
 Urokinase
 Recombinant tpa
 Alteplase
 Reteplase
Contraindications to thrombolysis
 Intolerable ischaemia(for arterial thrombosis)
 Active bleeding(not including menses)
 Recent stroke or neurosurgical procedure < 2 months
 Intracranial neoplasms
 Recent major surgery(<2 weeks), major trauma,parturition,
organ biopsy
 Active peptic ulcer or recent GI bleed(<2 weeks)
 Uncontrolled HTN
 Bacterial endocarditis, left heart thrombus, hemorrhagic
diabetic retinopathy
 Coagulopathy or current use of warfarin
 pregnancy
Endovascular aneurysm
repair(EVAR)
 Indications-
 Symptomatic aneurysm of any size
 Aneurysm >5.5cm in size(5 cm in females)
 Increase in diameter > 0.5 cm/yr
 Saccular aneurysms
 Poorly controlled HTN(DBP>100mmHg)
 Significant COPD(FEV1 <50% of predicted value)
 Contraindications-recent MI, intractable CHF,
unreconstructible CAD, life expectancy <2 yrs,
incapacitating neurologic disease after a stroke
 EVAR-suitable in 50% of infrarenal aneurysms
 Reduced mortality and morbidity, shorter hospital stay
 Similar rates of survival to open surgery
 Close follow up with CT necessary
 Unsuitable- short, flared or angulated neck, presence
of intraluminal thrombus and significant calcification,
renal artery/large accessory renal artery arising from
proximal neck, horseshoe kidney, iliac artery
tortuosity, calcification and luminal narrowing
 Complications
 Early-branch occlusion, distal embolization, graft
thrombosis and arterial injury
 Arterial dissection
 Bowel ischaemia, renal dysfunction
 Graft migration(1-6%)
 Endoleak- is defined as failure to exclude the
aneurysmal sac fully from arterial blood flow, potentially
predisposing to rupture of the aneurysm sac
Endovenous ablation of various
veins
 Endovenous laser ablation(EVLA)- 2001
 Radiofrequency ablation(RFA)
 Indicated in primary and recurrent varicose
veins(recurrent surgery-40% complication rate)
 Procedure includes the insertion of a probe into the greater
saphenous vein under usg guidance. Emits either laser or
radiofrequency energy, which coagulates the vein walls,
causing lumen obliteration.
 RFA-85-120 celsius
 Effectively treats junctional and truncal incompetence.
Varicosities are better treated with concomitant
phlebectomy
 Complications- pain. RFA>EVLA
 Skin burns
 DVT and pulmonary embolism(1%)
 Vein perforation and hematoma
 Paresthesia
 phlebitis(<5%)
 recurrence
 Tumescent anaesthesia-dilute
lidocaine+adrenaline+bicarbonate
 Max dose (xylocaine+ adrenaline)in tumescent
anaesthesia-45-50mg/kg body weight
 Provides analgesia, increasing contact with vein wall
and laser/RF, protect adjacent structures- skin, nerves
Embolisation
 Therapeutic embolization is a nonsurgical, minimally invasive
procedure performed by interventional radiologists and
interventional neuroradiologists . It involves the selective
occlusion of blood vessels by purposely introducing emboli.
 Recurrent hemoptysis
 Arteriovenous malformations(AVMs)
 Cerebral aneurysm
 Gastrointestinal bleeding
 Epistaxis
 Varicocele
 Primary post-partum hemorrhage
 Surgical hemorrhage
 Uterine fibroids
 Kidney lesions
 Liver lesions, typically hepatocellular carcinoma
(HCC). Treated either by particle infarction or
transcatheter arterial chemoembolization (TACE).
 Uterine fibroids
 Access to the organ by guidewire and catheter
 Location of the pathology by DSA
Embolic agents
 Liquid embolic agents
-used in AVMs. Flows through complex vascular
structures, so need not target each vessel
 N-butyl-2 cyanoacrylate
 Ethiodole
 onyx
 Sclerosing agents
-slow setting, cannot be used for large/high flow vessels
 Ethanol
 Ethanolamine oleate
 sotradecol
 Particulate embolic agents
 Gelfoam
-temporary occludes vessels
-used for hemostasis
 Poly vinyl alcohol(PVA)-
-microspheres of 50-1000 micron
-cause inflammatory reaction causing vessel occlusion
 Acrylic gelatin microspheres
 Mechanical occlusive device
 Coils
-used for AVM, aneurysm and trauma
-good for fast flowing vessels- immediately clot the
vessel. Platinum or steel
-induce clot due to dacron wool tails around the
wire
 Detachable baloon
- balloon implanted into a vessel, fill with saline
Advantages
 Minimally invasive
 No scarring
 Minimal risk of infection
 No or rare use of general anesthetic
 Faster recovery time
 High success rate compared to other procedures
 Preserves fertility and anatomical integrity
Disadvantages
 User dependent success rate
 Risk of emboli reaching healthy tissue potentially
causing gastric, stomach or duodenal ulcers. There are
methods, techniques and devices that decrease the
occurrence of this type of adverse side effect.
 Not suitable for everyone
 Recurrence more likely
Transcatheter arterial
chemoemolization
 Transcatheter arterial chemoembolization (also called
transarterial chemoembolization or TACE) is a minimally
invasive procedure performed in interventional radiology to
restrict a tumor's blood supply. Small embolic particles coated
with chemotherapeutic agents are injected selectively into an
artery directly supplying a tumor.
 two primary mechanisms.
- arterial embolization preferentially interrupts the tumor's blood
supply and stalls growth until neovascularization.
- focused administration of chemotherapy allows for delivery of a
higher dose to the tissue while simultaneously reducing systemic
exposure, which is typically the dose limiting factor. Effectively,
this results in a higher concentration of drug to be in contact
with the tumor for a longer period of time.
 Embolization induces ischemic necrosis of tumor
causing a failure of the transmembrane pump,
resulting in a greater absorption of agents by the
tumor cells. Tissue concentration of agents within the
tumor is greater than 40 times that of the surrounding
normal liver.
 Clinical applications- hepatocellular carcinoma,
neuroendocrine tumours, ocular melanoma,
cholangiocarcinoma, sarcoma, metastatic colon cancer
 Lipiodol- mixed with chemotherapeutic agents
 Drug eluting particles
-PVA microspheres-loaded with doxorubicin
COMPLICATIONS
-necrosis of tumours release cytokines causing pain,
fever and malaise
-intrahepatic abscess, irreversible hepatic necrosis
- Restrict TACE to single lobe or major branch of hepatic
artery
Thank you

Endovascular surgery

  • 1.
    Presenter: Dr AnilMeetei Moderator: Dr Th Chito Asst prof, CTVS
  • 2.
    Endovascular surgery Endovascular surgeryis a form of minimally invasive surgery/procedures for imaging the circulation or for treating vascular disorders from within the circulation, through catheters/miniature instruments inserted percutaneously into the blood vessels
  • 3.
    Scope of endovasculartherapy  Baloon angioplasty  Endovascular cryotherapy  Stenting  Angioscopy /intravascular ultrasound  Atherectomy  Thromb0embolectomy /intraarterial thrombolysis  Embolization  Endovascular aneurysm repair (EVAR)  Endovenous laser ablation (EVLA)  Endovascular RFA  Transcatheter aortic valve implantation (TAVI)  Percutaneous mitral valve repair
  • 4.
     Basic instruments Needles  Guidewires  Catheters  Sheaths
  • 5.
    Endovascular device sizing DEVICE MEASUREMENT UNIT 1. Entry needle outer diameter gauge 2. Guide wire outer diameter inch 3. Sheath inner diameter french 4. Guiding outer diameter french catheter 5. diagnostic outer diameter french catheter
  • 6.
     Common interventions Balloons  Stents  Stent grafts  Filters  Thrombolytics  Closure devices  IVUS
  • 8.
     Contrast media Ionic  Non ionic
  • 9.
    Contrast agents Iso osmolar-iodixanol,iotrolan(non ionic) Low osmolar Ionic dimer-meglumine ioxaglate Non ionic monomer- iopamidol, iohexol(omnipaque), ioversol, iopromide High osmolar Ionic monomer- meglumine diatrzoate(hypaque, gastrograffin, urograffin)
  • 10.
     ACCESS  Commonfemoral artery, popliteal, tibial, axillary, brachial, radial, carotid, subclavian  Bone/bony prominence beneath the artery  Avoid diseased areas  Away from side brances, bifurcations, or crossing veins  External skin markings, ultrasound guided, fluoroscopy
  • 11.
     Puncture site:common femoral artery on the medial 3rd of femoral head 1-2 cm below the inguinal ligament  A puncture site below the ligament cannot be compressed and could result in a large pelvic hemorrhage  Puncture of the SFA must be avoided to prevent pseudo-aneurysm and hematoma correlate to the inefficacy of the compression
  • 12.
     ACCESS  1.Retrograde-relatively large diameter, ease of compression, options for image guided puncture  2. Antegrade- commonly used for infrageniculate interventions, aortic bifurcations that are prohibitive to a contralateral retrograde CFA access and for chronic total occlusions  straight line approach- easy maneuvering
  • 13.
     ACCESS  1.Single wall Puncture  2. Double wall Puncture
  • 14.
    Guidewires  • Compositeconstruction  • Materials  – Stainless Steel  – Nitinol  – Jacketed Composite  Hydrophilic/hydrophobic
  • 15.
     • Core • Stainless Steel – Used for support – Stiffness varies based on taper / diameter of core  • Nitinol – Used for it’s flexibility, memory and kink resistance  • Tip  • Platinum / Gold – Provides radiopacity – Atraumatic – Ribbon formed for shaping tip
  • 16.
    Grind & tipperformance  • Stiff  • Intermediate  • Floppy
  • 18.
    Sheaths  Sheaths arehemostatic conduits inserted into the vessel. They allow passage of guidewires, catheters and interventional devices.  Hemostatic valve at the tip and a side port for aspiration/administration of drugs  Helps minimize local trauma to the vessel from repeated exchanges as well as decrease blood loss and hematoma formation
  • 20.
    Sheaths  Peripheral andcoronary sheaths have a universal color code  Universal color coding 4 Fr = red 5 Fr = gray 6 Fr = green 7 Fr = orange 8 Fr = blue 9 Fr = black 10 Fr = violet 11 Fr = yellow  Sheaths are measured inner diameter in french size (1fr = .33mm)
  • 21.
    catheters • Guide catheter •Diagnostic catheter • Non selective • Selective • Crossing
  • 22.
    Endovascular surgery  Typicallyperformed under LA  Less invasive  Quicker return to function  Durability compared to open surgical options  Highly skilled operator  Endovascular suite with fluoroscopy  Costly
  • 23.
    Complications of endovascular procedures Systemic, access site, or wire/catheter related complications  Contrast induced nephropathy  Increase age(>75 yrs), CRF(creatinine>1.5mg/dl), heart failure, DM, preprocedural hypotension, anaemia , ionic contrast medium  Proper hydration, Minimum contrast dose  Access site-MC  Hematoma(3%), thrombosis(2%), bleeding, AVF, pseudoaneurysm  Hematoma-reversal of anticoagulation, vol resuscitation, hematoma evacuation  Catheter related-  dissection, distal embolization, perforation
  • 24.
    Seldinger technique  SvenIvar Seldinger- Swedish radiologist (1953)  The Seldinger technique is a medical procedure to obtain safe access to blood vessels  The desired vessel is punctured with a sharp hollow needle called a trocar, with ultrasound guidance .  Guidewire is then advanced through the lumen of the trocar, and the trocar is withdrawn. A "sheath" or blunt cannula is passed over the guidewire into the cavity or vessel. After passing a sheath or tube, the guidewire is withdrawn.  A sheath can be used to introduce catheters or other devices to perform endoluminal procedures.  Fluoroscopy is used to confirm the position of the catheter and to manoeuvre it to the desired location. Injection of radiocontrast may be used to visualize organs.  Upon completion of the desired procedure, the sheath is withdrawn. a sealing device may be used to close the hole made by the procedure.
  • 26.
    Balloon angioplasty  Fogarthy(1963)- used endovascular catheter for extraction of arterial emboli and thrombi  Dotter and Judkins (1964)-transluminal treatment of arterial stenosis  Types  Percutaneous transluminal angioplasty (PTA)  Subintimal angioplasty  PTA with stenting
  • 27.
    Technique  Shortest distancefrom the access vessel to the target vessel  Retrograde right common femoral artery access  Tibial occlusive disease-I/L anterior common femoral access  Heparinization-5000 IU as standard bolus dose after arterial access. 1000 IU/L heparinized saline for flushing  Arteriography to identify the lesion and severity  Lesion crossed and contrast injected  Balloon diameter and length carefully chosen  IVUS/CTA- for sizing the lesion  Balloon inflated for 1 min, withrawn after deflating  Contrast injection to assess the PTA result
  • 28.
     Iliac andfemoro popliteal segments. Less successful for below knee narrowing  Coronary arteries  Complications- failure, hematoma formation, bleeding, thrombosis, distal embolisation
  • 30.
    Subintimal angioplasty  Boliaet al (1989)-for chronic total occlusions  Creating an intentional subintimal plane across the occlusion with a guidewire and wire redirected back into the true lumen  Iliac and femoropopliteal occlusions- successful in highly calcified lesions, long occlusions(>15 cm)  Higher patency rates were observed in limbs treated for claudication than limbs treated for chronic total occlusions and criticallimb ischaemia  12 month patency <70%  Mean increase in ABI is 0.3  Technical failure rate ~26%- mostly due to inability to reenter the true lumen distal to the occlusion(70%)
  • 32.
     Types ofballoon  Complaint balloon  Non complaint balloon Complaint balloon –expand in the direction of least resistance - more potential for arterial injury -potentially treat vessels of varying diameter Non complaint balloon -polyolefin copolymer/polyethylene/nylon reinforcement -provide higher uniform dilating force –highly calcific lesions
  • 33.
     Cutting balloonangioplasty-  Ballon loaded with metal atherotome or microsurgical blades  Designed to create controlled incisions into the thrombus and dilate the vessel with less force than conventional balloon angioplasty  CBA- reasonable option for infrainguinal vein graft stenosis -superior results to PTA -more chance of perforation
  • 34.
     Endovascular cryotherapy Balloon catheter inflated with nitrous oxide delivering cold thermal energy(-10 C) to the arterial wall.  Alters healing response after angioplasty, principally inducing smooth muscle cell apoptosis rather than necrosis, thus reducing myointimal hyperplasia  CLIMB study -initial success rate 95% -stents required in 17% -primary patency at 12 months @56% and comparible with those achieved with conventional PTA -recommended for lesions >55mm
  • 35.
     Drug coatedballoons(DCBs)  Substantial amounts of antiproliferative agents were delivered to the arterial wall during short periods of balloon inflation.  For prevention of re stenosis and myointimal hyperplasia  Paclitaxel coated balloons deliver drug during balloon inflation( superficial femoral artery)  Drug eluting stents (DES) -coronary circulation/infrainguinal arterial occlusive disease -Sirolimus/paclitaxel-inhibits smooth muscle cell proliferation
  • 36.
    Stenting  Stent-comes from19th century London dentist- Charles Stent  Charles Dotter (1983)-nitinol stents were first used  Palmaz et al (1985)-balloon expandable stent  Two types  Bare metal stent  Stent graft  Two types based on deployment method  Balloon expandable  Self expanding
  • 38.
    Balloon expandable Selfexpandable  High radial/longitudinal force  Precise placement  Further expansion with larger balloons  Radiopaque  Short length  Prone to crushing  Flexibility  Long stent lengths  Continued radial force if oversized  Crush resistant  Ability to clamp the stent  Low radial force  Inaccurate/less precise placement  Limited radiopacity
  • 39.
    Angioscopy  Used forvisualizing the interior of blood vessels  Arterial embolism, adjunctive procedure during vascular bypass to visualize valves within venous conduit  Visualize stents in catheterization lab
  • 40.
    Intravascular ultrasound  Usesminiature ultrasound probe attached to distal end of an intravascular catheter(uses 20-40MHz)  Useful with unreliable angiographic images-lumen of ostial lesions, or in regions with multiple overlapping arterial segments  Advantages over angiography-measures atheroma hidden within the vessel wall, identifies vulnerable plaque. Measures the effect of different treatment strategies for changing the evolution of the atherosclerosis disease process
  • 42.
    Atherectomy  Endovascular atherectomyallows the physical removal of atherosclerotic plaque material from the blood vessel, with a theoretical benefit of removing the obstructing plaque rather than mere displacing it, as with angioplasty and stenting  Open atherectomy remains the gold standard. Endovascular atherectomy is useful in vessels with difficult access  Excisional atherectomy catheters remove and collect the atheroma, whereas ablative device fragment the atheroma into small particles  3 types of atherectomy devices  Directional  Rotational  Laser
  • 43.
     Directional atherectomy Best suited for discrete calcified atherosclerotic lesions of infrainguinal arteries. Not used for chronic total occlusion  Silverhawk plaque excision system-the device is advanced under fluoroscopic guidance to the proximal portion of the target lesion, where a carbide cutter excise the atheroma and traps it within the nose come of the device; once filled with plaque the device is removed, the nose cone is emptied, and the device is reintroduced over a guidewire
  • 45.
     Rotational atherectomyutilizes a rotating burr or blade to excise plaque, whose microparticles are either aspirated or allowed to embolize distally  Jetstream – device success rate 99%.TLR -15% and 26% at 6 and 12 months respectively; restonosis 38% at 1yr  May cause vasospasm-calcium channel blockers/ nitroglycerine
  • 46.
     Laser atherectomy Utilized in CTOs, both de novo or in in stent thrombosis  Cold tip laser that delivers burst of ultraviolet xenon energy in short pulse duration.  Key features is the ability to debulk tissue without damaging surrounding tissue, minimizing restenosis COMPLICATIONS -embolism 1.3%
  • 47.
    Thromboembolectomy  Management ofacute thrombotic or embolic arterial occlusions  Fogarty catheter  Purely percutaneous thrombolectomy  Aspiration  Rheolytic devices  Mechanical fragmentation with or without pharmacologic lysis
  • 49.
     Simple aspirationeither via a large sheath or guide catheter work well in small vessels< 6mm  Rheolytic devices utilize jets of saline, directed from the tip of the catheter back toward its more proximal portion, to create a venturi effect, resulting in clot lysis and aspiration.  Arterial access is ideally made antegrade to the area of thrombotic occlusion. Lower extremity lesions are approached through contralateral femoral artery
  • 51.
    Inferior vena cavafilter  Prevent life threatening pulmonary emboli  Retrievable/ permanent  Indications  DVT/PE with contraindications to anticoagulation  Recurrent VTE despite adequate anticoagulation  Poor patient compliance(INR unstable), thrombolysis Complications-device migration, filter embolization, filter fracture, perforation of IVC, recurrent DVT, vena cava thrombosis
  • 53.
    Intraarterial thrombolysis  InIA thrombolysis, the cervicocephalic arterial tree is traversed with an endovascular microcatheter delivery system, the catheter port is positioned immediately within and adjacent to the offending thrombus, and fibrinolytic agents are infused directly into the clot. This delivery technique permits high concentrations of lytic agent to be applied to the clot while minimizing systemic exposure.  In acute ischaemic stroke within 6 hours of symptom onset  It is usually infused over 1 to 2 hours while serial angiographic studies are obtained  reduced hemorrhagic complications (due to the use of lower doses of pharmacologic thrombolytics
  • 54.
     Myocardial infarction,ischaemic stroke, massive PE, acute limb ischaemia  Recanalization rates for IAT have been shown to be superior to those for IVT for major cerebrovascular occlusions, averaging 70% versus 34%  Agents used  Streptokinase  Urokinase  Recombinant tpa  Alteplase  Reteplase
  • 55.
    Contraindications to thrombolysis Intolerable ischaemia(for arterial thrombosis)  Active bleeding(not including menses)  Recent stroke or neurosurgical procedure < 2 months  Intracranial neoplasms  Recent major surgery(<2 weeks), major trauma,parturition, organ biopsy  Active peptic ulcer or recent GI bleed(<2 weeks)  Uncontrolled HTN  Bacterial endocarditis, left heart thrombus, hemorrhagic diabetic retinopathy  Coagulopathy or current use of warfarin  pregnancy
  • 56.
    Endovascular aneurysm repair(EVAR)  Indications- Symptomatic aneurysm of any size  Aneurysm >5.5cm in size(5 cm in females)  Increase in diameter > 0.5 cm/yr  Saccular aneurysms  Poorly controlled HTN(DBP>100mmHg)  Significant COPD(FEV1 <50% of predicted value)  Contraindications-recent MI, intractable CHF, unreconstructible CAD, life expectancy <2 yrs, incapacitating neurologic disease after a stroke
  • 57.
     EVAR-suitable in50% of infrarenal aneurysms  Reduced mortality and morbidity, shorter hospital stay  Similar rates of survival to open surgery  Close follow up with CT necessary  Unsuitable- short, flared or angulated neck, presence of intraluminal thrombus and significant calcification, renal artery/large accessory renal artery arising from proximal neck, horseshoe kidney, iliac artery tortuosity, calcification and luminal narrowing
  • 59.
     Complications  Early-branchocclusion, distal embolization, graft thrombosis and arterial injury  Arterial dissection  Bowel ischaemia, renal dysfunction  Graft migration(1-6%)  Endoleak- is defined as failure to exclude the aneurysmal sac fully from arterial blood flow, potentially predisposing to rupture of the aneurysm sac
  • 61.
    Endovenous ablation ofvarious veins  Endovenous laser ablation(EVLA)- 2001  Radiofrequency ablation(RFA)  Indicated in primary and recurrent varicose veins(recurrent surgery-40% complication rate)  Procedure includes the insertion of a probe into the greater saphenous vein under usg guidance. Emits either laser or radiofrequency energy, which coagulates the vein walls, causing lumen obliteration.  RFA-85-120 celsius  Effectively treats junctional and truncal incompetence. Varicosities are better treated with concomitant phlebectomy
  • 62.
     Complications- pain.RFA>EVLA  Skin burns  DVT and pulmonary embolism(1%)  Vein perforation and hematoma  Paresthesia  phlebitis(<5%)  recurrence
  • 63.
     Tumescent anaesthesia-dilute lidocaine+adrenaline+bicarbonate Max dose (xylocaine+ adrenaline)in tumescent anaesthesia-45-50mg/kg body weight  Provides analgesia, increasing contact with vein wall and laser/RF, protect adjacent structures- skin, nerves
  • 64.
    Embolisation  Therapeutic embolizationis a nonsurgical, minimally invasive procedure performed by interventional radiologists and interventional neuroradiologists . It involves the selective occlusion of blood vessels by purposely introducing emboli.  Recurrent hemoptysis  Arteriovenous malformations(AVMs)  Cerebral aneurysm  Gastrointestinal bleeding  Epistaxis  Varicocele  Primary post-partum hemorrhage  Surgical hemorrhage  Uterine fibroids
  • 65.
     Kidney lesions Liver lesions, typically hepatocellular carcinoma (HCC). Treated either by particle infarction or transcatheter arterial chemoembolization (TACE).  Uterine fibroids  Access to the organ by guidewire and catheter  Location of the pathology by DSA
  • 66.
    Embolic agents  Liquidembolic agents -used in AVMs. Flows through complex vascular structures, so need not target each vessel  N-butyl-2 cyanoacrylate  Ethiodole  onyx  Sclerosing agents -slow setting, cannot be used for large/high flow vessels  Ethanol  Ethanolamine oleate  sotradecol
  • 67.
     Particulate embolicagents  Gelfoam -temporary occludes vessels -used for hemostasis  Poly vinyl alcohol(PVA)- -microspheres of 50-1000 micron -cause inflammatory reaction causing vessel occlusion  Acrylic gelatin microspheres
  • 68.
     Mechanical occlusivedevice  Coils -used for AVM, aneurysm and trauma -good for fast flowing vessels- immediately clot the vessel. Platinum or steel -induce clot due to dacron wool tails around the wire  Detachable baloon - balloon implanted into a vessel, fill with saline
  • 71.
    Advantages  Minimally invasive No scarring  Minimal risk of infection  No or rare use of general anesthetic  Faster recovery time  High success rate compared to other procedures  Preserves fertility and anatomical integrity
  • 72.
    Disadvantages  User dependentsuccess rate  Risk of emboli reaching healthy tissue potentially causing gastric, stomach or duodenal ulcers. There are methods, techniques and devices that decrease the occurrence of this type of adverse side effect.  Not suitable for everyone  Recurrence more likely
  • 73.
    Transcatheter arterial chemoemolization  Transcatheterarterial chemoembolization (also called transarterial chemoembolization or TACE) is a minimally invasive procedure performed in interventional radiology to restrict a tumor's blood supply. Small embolic particles coated with chemotherapeutic agents are injected selectively into an artery directly supplying a tumor.  two primary mechanisms. - arterial embolization preferentially interrupts the tumor's blood supply and stalls growth until neovascularization. - focused administration of chemotherapy allows for delivery of a higher dose to the tissue while simultaneously reducing systemic exposure, which is typically the dose limiting factor. Effectively, this results in a higher concentration of drug to be in contact with the tumor for a longer period of time.
  • 74.
     Embolization inducesischemic necrosis of tumor causing a failure of the transmembrane pump, resulting in a greater absorption of agents by the tumor cells. Tissue concentration of agents within the tumor is greater than 40 times that of the surrounding normal liver.  Clinical applications- hepatocellular carcinoma, neuroendocrine tumours, ocular melanoma, cholangiocarcinoma, sarcoma, metastatic colon cancer
  • 76.
     Lipiodol- mixedwith chemotherapeutic agents  Drug eluting particles -PVA microspheres-loaded with doxorubicin COMPLICATIONS -necrosis of tumours release cytokines causing pain, fever and malaise -intrahepatic abscess, irreversible hepatic necrosis - Restrict TACE to single lobe or major branch of hepatic artery
  • 77.